TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22142410

Group type: EXPERIMENTAL
Intervention: Exercise + Amino Acid Supplementation (AAS)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Amino Acid Supplementation (AAS)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 155
Study: 20061070

Group type: EXPERIMENTAL
Intervention: Taurolidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 30
Study: 18439948

Group type: EXPERIMENTAL
Intervention: Acyclovir plus prednisone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 91
Study: 16652039

Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 3234

Group type: EXPERIMENTAL
Intervention: Behavioral interventions with motivational and skills components
Number of subjects: 3234
Study: 12631138

Group type: COMPARATOR
Intervention: Four hours of hemodialysis (SD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Eight hours of hemodialysis
Number of subjects: 8

Group type: COMPARATOR
Intervention: Eight hours of hemodialysis using a smaller dialyzer and slower blood pump
Number of subjects: 8
Study: 11040164

Group type: EXPERIMENTAL
Intervention: Dexamethasone (3-day course)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 248
Study: 8617710

Group type: EXPERIMENTAL
Intervention: Haloperidol plus sertraline (200 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Haloperidol (2 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sertraline (50 to 200 mg/day)
Number of subjects: 24
Study: 8500374

Group type: EXPERIMENTAL
Intervention: Preoperative short-term high-dose irradiation (25.5 Gy in one week)
Number of subjects: 471

Group type: COMPARATOR
Intervention: Postoperative radiotherapy (60 Gy in seven to eight weeks)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 471

Group type: COMPARATOR
Intervention: Postoperative irradiation
Number of subjects: 471

Group type: COMPARATOR
Intervention: Nonirradiated patients
Number of subjects: 471
Study: 3552697

Group type: EXPERIMENTAL
Intervention: Fosfomycin trometamol salt (FT)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Amoxycillin (AMX)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Co-trimoxazole (CTX)
Number of subjects: 675
Study: 29704966

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention, consisting of four 2.5-hour workshops over a 4-week period, with home exercises (e.g., meditation, observation grids)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention
Number of subjects: 144

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 144
Study: 27778333

Group type: EXPERIMENTAL
Intervention: Nursing Home Compare Plus (NHCPlus)
Number of subjects: 225
Study: 25274787

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation protocol
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard rehabilitation protocol
Number of subjects: 81
Study: 23269680

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab plus ablative therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ablative therapy alone
Number of subjects: 20
Study: 21381350

Group type: EXPERIMENTAL
Intervention: Cyclopheron
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 17909829

Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted partial tonsillectomy (group 1)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Electrocautery-assisted total tonsillectomy (group 2)
Number of subjects: 143
Study: 15758000

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300-mg loading dose, followed by 75 mg once daily)
Number of subjects: 3491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 3491
Study: 12753270

Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 0
Study: 12858934

Group type: EXPERIMENTAL
Intervention: Daycare hernia repair (61 patients)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Inpatient hernia repair (60 patients)
Number of subjects: 121
Study: 8795597

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 1630347

Group type: EXPERIMENTAL
Intervention: Nebuhaler/MDI (metered dose aerosol terbutaline)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nebulised wet aerosol terbutaline
Number of subjects: 61
Study: 3934548

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine gum combined with behavioral treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 0
Study: 30615055

Group type: EXPERIMENTAL
Intervention: Falls prevention exercise programme based on the Otago Exercise Programme (OEP)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 155
Study: 29873076

Group type: EXPERIMENTAL
Intervention: Low mast cell density (MCD)
Number of subjects: 854
Study: 27494722

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 60
Study: 25054836

Group type: EXPERIMENTAL
Intervention: Active gamma ventral capsulotomy (GVC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham GVC
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham GVC followed by active GVC
Number of subjects: 16
Study: 22517385

Group type: EXPERIMENTAL
Intervention: Dynamic splinting
Number of subjects: 66

Group type: COMPARATOR
Intervention: Static splinting
Number of subjects: 66
Study: 20355244

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (CRT)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Postoperative chemoradiotherapy (CRT)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Surgery alone (S)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Preoperative CRT
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Postoperative CRT
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Local recurrence rates
Number of subjects: 238
Study: 18584466

Group type: EXPERIMENTAL
Intervention: 14 mg nicotine patches
Number of subjects: 56

Group type: COMPARATOR
Intervention: placebo patches
Number of subjects: 56
Study: 16110845

Group type: EXPERIMENTAL
Intervention: H. pylori eradication treatment
Number of subjects: 21
Study: 11756072

Group type: EXPERIMENTAL
Intervention: Isolated soy protein (ISP) containing 56 mg isoflavones (ISP56)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Isolated soy protein (ISP) containing 90 mg isoflavones (ISP90)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (casein from nonfat dry milk)
Number of subjects: 73
Study: 10081993

Group type: COMPARATOR
Intervention: Low-dose IVAA (125 mg protein/kg/h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: High-dose IVAA (250 mg protein/kg/h)
Number of subjects: 6

Group type: COMPARATOR
Intervention: i.v. saline (control)
Number of subjects: 6
Study: 8585105

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 54
Study: 2210608

Group type: EXPERIMENTAL
Intervention: Cisapride 40 mg (q.i.d.)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Cisapride 20 mg (b.i.d.)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Cimetidine 1600 mg (q.i.d.)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Cimetidine 800 mg (b.i.d.)
Number of subjects: 129
Study: 508701

Group type: EXPERIMENTAL
Intervention: Ascorbic acid 500 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium caseinate 15 g/d
Number of subjects: 0
Study: 31987544

Group type: EXPERIMENTAL
Intervention: Upper limb Robot‐assisted Therapy (RT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional physical Therapy (TT)
Number of subjects: 48
Study: 30244073

Group type: COMPARATOR
Intervention: No CE and no ICAS
Number of subjects: 140

Group type: COMPARATOR
Intervention: ICAS without CE
Number of subjects: 140

Group type: COMPARATOR
Intervention: CE without ICAS
Number of subjects: 140

Group type: COMPARATOR
Intervention: CE and ICAS
Number of subjects: 140
Study: 27916241

Group type: EXPERIMENTAL
Intervention: No-touch technique (group NT)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Minimal manipulation technique (group MM)
Number of subjects: 368
Study: 25886875

Group type: EXPERIMENTAL
Intervention: Mindfulness-based exposure and response prevention (MB-ERP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Exposure and response prevention (ERP)
Number of subjects: 40
Study: 23748448

Group type: EXPERIMENTAL
Intervention: High-alcohol mouthwash
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-alcohol mouthwash
Number of subjects: 50

Group type: COMPARATOR
Intervention: Negative control mouthwash
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Drinkers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nondrinkers rinsing with high-alcohol mouthwash
Number of subjects: 50
Study: 21385432

Group type: EXPERIMENTAL
Intervention: Didactic teaching and self‐directed learning (DT/SDL)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Didactic teaching (DT)
Number of subjects: 205
Study: 19302904

Group type: EXPERIMENTAL
Intervention: Compliance device with grass allergen tablets
Number of subjects: 91
Study: 17391286

Group type: EXPERIMENTAL
Intervention: Simultaneous confidence intervals for several designs and aims in clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous confidence intervals for the difference or the ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous intervals for dose-finding trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional testing of all hypotheses at level alpha
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion of other multiplicity issues
Number of subjects: 0
Study: 15492300

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (3 g at least 2 hours before the procedure and 2 g in the night and the morning after the procedure)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 231
Study: 11235926

Group type: EXPERIMENTAL
Intervention: Olanzapine (5, 10, or 15 mg/day)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 206
Study: 9744770

Group type: EXPERIMENTAL
Intervention: 6-thioguanine (6TG)
Number of subjects: 73

Group type: COMPARATOR
Intervention: 6-mercaptopurine (6MP)
Number of subjects: 73
Study: 7921452

Group type: EXPERIMENTAL
Intervention: High frequency chest compression (HFCC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CPT)
Number of subjects: 50
Study: 3057997

Group type: EXPERIMENTAL
Intervention: Transfer of pronuclear embryos (day 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transfer of cleavage embryos (day 2)
Number of subjects: 0
Study: 1134717

Group type: COMPARATOR
Intervention: Scheie's procedure
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with a sutured scleral flap
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Scheie's procedure and Trabeculectomy
Number of subjects: 71
Study: 31939321

Group type: EXPERIMENTAL
Intervention: Cluster nursing measures in combination with continuous phototherapy (blue light)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Routine nursing together with continuous phototherapy (blue light)
Number of subjects: 141
Study: 30419153

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE)
Number of subjects: 22
Study: 28576897

Group type: EXPERIMENTAL
Intervention: Sleep intervention (antenatal education session and home visit at 3 weeks postpartum)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: FAB and combination groups (food, activity and breastfeeding intervention)
Number of subjects: 802
Study: 25942417

Group type: EXPERIMENTAL
Intervention: Gadolinium-based contrast agent (GBCA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-gadolinium-based contrast agent (non-GBCA)
Number of subjects: 10
Study: 23287637

Group type: EXPERIMENTAL
Intervention: Insecure-avoidant infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Secure infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Insecure-ambivalent infants
Number of subjects: 84

Group type: COMPARATOR
Intervention: Attachment groups at 5 months
Number of subjects: 84
Study: 21664710

Group type: EXPERIMENTAL
Intervention: 40-45Gy in 20-23 fractions for indolent NHL
Number of subjects: 1001

Group type: COMPARATOR
Intervention: 24Gy in 12 fractions for indolent NHL
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: 40-45Gy in 20-23 fractions for aggressive NHL
Number of subjects: 1001

Group type: COMPARATOR
Intervention: 30Gy in 15 fractions for aggressive NHL
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Low-dose arms (24Gy for indolent NHL and 30Gy for aggressive NHL)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Standard doses (40-45Gy)
Number of subjects: 1001
Study: 18047499

Group type: EXPERIMENTAL
Intervention: IV DEX (15 mg)
Number of subjects: 126

Group type: COMPARATOR
Intervention: PLA (placebo)
Number of subjects: 126
Study: 16183189

Group type: COMPARATOR
Intervention: NMC group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Follicular prorenin concentrations in PCOS
Number of subjects: 55
Study: 12680834

Group type: EXPERIMENTAL
Intervention: Ventilation tubes with adenoidectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ventilation tubes without adenoidectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ears with functioning ventilation tubes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ears without OME after tube extrusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tube blockage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ventilation tubes
Number of subjects: 0
Study: 10875182

Group type: EXPERIMENTAL
Intervention: Laser-based technique for measuring accuracy and distortion in judgments of linear dimensions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser-based technique
Number of subjects: 0
Study: 9170037

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.1 mmol/kg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.2 mmol/kg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.3 mmol/kg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.1 mmol/kg at 2 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.2 mmol/kg at 2 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.3 mmol/kg at 2 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.1 mmol/kg at 5 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.2 mmol/kg at 5 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection at 0.3 mmol/kg at 5 ml/second
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: sprodiamide injection
Number of subjects: 35
Study: 1492860

Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 6 mg tablet
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) 3 ml drops (2 mg/ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dihydroergocristine (DHEC) single-dose bottle (6 mg)
Number of subjects: 6
Study: 3514474

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 116

Group type: COMPARATOR
Intervention: Pipemidic acid
Number of subjects: 116

Group type: COMPARATOR
Intervention: Co-trimoxazole forte
Number of subjects: 116
Study: 31646578

Group type: EXPERIMENTAL
Intervention: SOX9 siRNA
Number of subjects: 0

Group type: COMPARATOR
Intervention: High glucose group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30095593

Group type: EXPERIMENTAL
Intervention: Sun Safe Workplaces (SSW) program
Number of subjects: 1724
Study: 27931302

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microgram daily dose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microgram daily combined with LABA (formoterol)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microgram daily combined with LTRA (montelukast)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microgram daily dose
Number of subjects: 80
Study: 23183711

Group type: EXPERIMENTAL
Intervention: Bromocriptine (dopamine‐receptor agonist)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sulpiride (dopamine‐receptor antagonist)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of bromocriptine and sulpiride
Number of subjects: 22
Study: 22244646

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA) in phosphate-buffered saline (PBS) (pH = 7.4) for 4 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bioaggregate (BA) in phosphate-buffered saline (PBS) (pH = 7.4) for 4 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA) in acetic acid (pH = 5.4) for 4 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bioaggregate (BA) in acetic acid (pH = 5.4) for 4 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA) in phosphate-buffered saline (PBS) for 34 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA) in PBS for 34 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bioaggregate (BA) in PBS for 34 days
Number of subjects: 80
Study: 19189319

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplant (HSCT) couples
Number of subjects: 121
Study: 16960155

Group type: EXPERIMENTAL
Intervention: Daily multivitamin supplementation (5 mg folic acid, 50 mg pyridoxine, and 0.4 mg cyanocobalamin)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 701
Study: 15747154

Group type: EXPERIMENTAL
Intervention: [(18)F]FDG-PET
Number of subjects: 26
Study: 12456421

Group type: EXPERIMENTAL
Intervention: Ketamine 3.0 or 3.5 mg/kg with lidocaine spray
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketamine (various doses)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol (various doses)
Number of subjects: 90
Study: 10479851

Group type: EXPERIMENTAL
Intervention: Alprostadil (60 micrograms in 250 cc of physiological infusion for six consecutive days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (250 cc of physiological infusion administered in the same manner)
Number of subjects: 12
Study: 8686826

Group type: EXPERIMENTAL
Intervention: Doxacurium with halothane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Doxacurium with isoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Doxacurium with alfentanil
Number of subjects: 30
Study: 1878531

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (200 mg)
Number of subjects: 10
Study: 6958487

Group type: EXPERIMENTAL
Intervention: Budesonide (400 micrograms daily, administered twice a day)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Becotide Nasal (400 micrograms daily, administered four times a day)
Number of subjects: 93
Study: 31027889

Group type: EXPERIMENTAL
Intervention: Lung ultrasound-guided dry-weight reduction
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard-of-care treatment
Number of subjects: 71
Study: 29977265

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (group A, n=40)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Resistance exercise (group B, n=40)
Number of subjects: 60
Study: 26868369

Group type: EXPERIMENTAL
Intervention: Inhaled mometasone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Adaptive randomization
Number of subjects: 45

Group type: COMPARATOR
Intervention: Simple randomization
Number of subjects: 45

Group type: COMPARATOR
Intervention: Block randomization
Number of subjects: 45
Study: 25132278

Group type: EXPERIMENTAL
Intervention: Inhaled cationic airway lining modulator (iCALM) - 1.29% calcium chloride in 0.9% isotonic saline
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 22378177

Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation (tDCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cathodal cerebellar transcranial direct current stimulation (tDCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cerebellar tDCS (both anodal and cathodal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS
Number of subjects: 0
Study: 19942107

Group type: EXPERIMENTAL
Intervention: Yoga sessions lasting 60 min daily
Number of subjects: 88

Group type: COMPARATOR
Intervention: Brief supportive therapy once in 10 days
Number of subjects: 88
Study: 17439537

Group type: EXPERIMENTAL
Intervention: Mothers' reports of immunisations
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mothers' reports of infant doctors' visits
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Mothers' reports of sick-baby visits
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Agreement between mothers' reports and medical records
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Discrepancies in reporting
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Emergency room visits
Number of subjects: 160
Study: 15782505

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.02 mg/kg) and atropine (0.01 mg/kg) infusion in group C and group D after neuromuscular recovery (T1/T(C)) reached 10%.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Magnesium sulfate (MgSO4) 30 mg/kg in saline intravenously within 5 min in group A and group C.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline infusion in group B and group D.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neostigmine and atropine infusion in group C and group D.
Number of subjects: 40